Literature DB >> 10760798

Role of Qa-1(b)-binding receptors in the specificity of developing NK cells.

M Salcedo1, F Colucci, P J Dyson, L A Cotterill, F A Lemonnier, P Kourilsky, J P Di Santo, H G Ljunggren, J P Abastado.   

Abstract

NK cells acquire the ability to recognize MHC class I molecules during development. Studies with Qa-1(b) tetramers (Qa-1 tetramers) showed that nearly all NK1.1(+) cells from newborn C57BL/6 mice express Qa-1-binding receptors. Cytotoxic activity of these cells is fully inhibited by Qa-1 ligands on target cells. In contrast, neither receptors for H-2K(b) nor H-2D(b) were observed on NK1.1(+) cells from newborn mice. After birth, frequencies of Qa-1 tetramer(+)/ NK1.1(+) cells gradually decrease as the number of Ly49(+) /NK1.1(+) cells increases. Cell transfer studies showed that Qa-1 tetramer(+) cells from newborn mice do not lose expression of Qa-1 receptors, but that they further acquire expression of Ly49 molecules. Acquisition of Qa-1-binding receptors appears largely independent of host MHC class I molecules, as observed in studies using beta2-microglobulin-deficient (beta2m(-/-)) mice as well as K(b)/ D(b-/-) and K(b)/D(b)/beta2m(-/-) mice. The present results suggest that Qa-1-binding receptors play an important role in the specificity of developing NK cells, and suggest that these cells rely mainly on inhibitory receptors specific for non-classical MHC class I molecules to maintain self tolerance during the first weeks of life.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10760798     DOI: 10.1002/(SICI)1521-4141(200004)30:4<1094::AID-IMMU1094>3.0.CO;2-9

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice.

Authors:  Simon Bélanger; Megan M Tu; Mir Munir Ahmed Rahim; Ahmad B Mahmoud; Rajen Patel; Lee-Hwa Tai; Angela D Troke; Brian T Wilhelm; Josette-Renée Landry; Qinzhang Zhu; Kenneth S Tung; David H Raulet; Andrew P Makrigiannis
Journal:  Blood       Date:  2012-06-01       Impact factor: 22.113

Review 2.  Qa-1, a nonclassical class I histocompatibility molecule with roles in innate and adaptive immunity.

Authors:  Peter E Jensen; Barbara A Sullivan; Lisa M Reed-Loisel; Dominique A Weber
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

3.  Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation.

Authors:  Russell E Vance; Amanda M Jamieson; Dragana Cado; David H Raulet
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

4.  Arrested natural killer cell development associated with transgene insertion into the Atf2 locus.

Authors:  Sungjin Kim; Yun-Jeong Song; Darryl A Higuchi; Hyunseok P Kang; Jennifer R Pratt; Liping Yang; Caron M Hong; Jennifer Poursine-Laurent; Koho Iizuka; Anthony R French; John B Sunwoo; Shunsuke Ishii; Andreas M Reimold; Wayne M Yokoyama
Journal:  Blood       Date:  2005-10-13       Impact factor: 22.113

5.  MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response.

Authors:  Makoto Yawata; Nobuyo Yawata; Monia Draghi; Fotini Partheniou; Ann-Margaret Little; Peter Parham
Journal:  Blood       Date:  2008-06-26       Impact factor: 22.113

6.  Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes.

Authors:  J R Kraft; R E Vance; J Pohl; A M Martin; D H Raulet; P E Jensen
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

Review 7.  Mammalian non-classical major histocompatibility complex I and its receptors: Important contexts of gene, evolution, and immunity.

Authors:  B M Pratheek; Tapas K Nayak; Subhransu S Sahoo; Prafulla K Mohanty; Soma Chattopadhyay; Ntiya G Chakraborty; Subhasis Chattopadhyay
Journal:  Indian J Hum Genet       Date:  2014-04

Review 8.  Paths taken towards NK cell-mediated immunotherapy of human cancer-a personal reflection.

Authors:  Hans-Gustaf Ljunggren
Journal:  Scand J Immunol       Date:  2020-11-20       Impact factor: 3.487

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.